Effect of agomelatine on intestinal smooth muscle contractility in rats

Aim: The purpose of the present study was to investigate in vitro the effect of agomelatine, an analog of melatonin, on potassium chloride-stimulated contractions (KCl) in duodenum, jejunum, ileum, and colon in rats. Materials and Methods: A total of 7 Wistar albino female rat strips were used in the study. Rats were 8-10 weeks old and weighed 200-250 g. After the rats were decapitated without anesthesia, duodenum, jejunum, ileum, and colon strips were prepared and placed in the organ bath. Agomelatine was applied in doses of 100, 200, and 1000 μM to the strips that were contracted with KCl (80 mM). Then, 1000 μM agomelatine was applied after preliminary treatment of melatonin receptor antagonist luzindole (1 μM) to investigate the action mechanism of agomelatine on intestinal smooth muscles. The records were analyzed before and after each dose, and frequency, peak to peak (P-P) and area values were compared. Results: Agomelatine inhibited the KCI- induced contractions in duodenum, jejunum, ileum, and colon strips in a dose-dependent manner. Depending on the agomelatine application, the frequency, “P-P”, and the area values under the curve decreased at statistically significant levels (p<0.05). However, the effect of agomelatine decreased at significant levels as a result of luzindole treatment (p<0.05). Conclusion: The dose-dependent inhibitor effect of agomelatine on KCl-stimulated contractions in the rat intestinal smooth muscle was shown for the first time in this study. Agomelatine was found to affect the smooth muscles of the intestines through melatonin receptors. This result suggests that agomelatine might have therapeutic potential in diseases in which gastrointestinal motility is impaired.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Acuña-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014;71(16):2997-3025. doi:10.1007/s00018-014-1579-2.
2. Carpentieri A, Díaz de Barboza G, Areco V, et al. New perspectives in melatonin uses. Pharmacol Res. 2012;65(4):437-444. doi:10.1016/j.phrs.2012.01.003.
3. Mukherjee S, Maitra SK. Gut Melatonin in Vertebrates: Chronobiology and Physiology. Front Endocrinol (Lausanne). 2015;6:112. Published 2015 Jul 22. doi:10.3389/fendo.2015.00112.
4. Tordjman S, Chokron S, Delorme R, et al. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017;15(3):434-443. doi:10.2174/1570159X14666161228122115.
5. Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. Journal of the American Chemical Society 1958;80(10):2587-2587. doi:10.1021/ja01543a060.
6. Huether G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia. 1993;49(8):665-670. doi:10.1007/BF01923948.
7. Huether G. Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin. Ann N Y Acad Sci. 1994;719:146-158. doi:10.1111/j.1749- 6632.1994.tb56826.x.
8. Huether G, Messner M, Rodenbeck A, et al. Effect of continuous melatonin infusions on steady-state plasma melatonin levels in rats under near physiological conditions. J Pineal Res. 1998;24(3):146-151. doi:10.1111/j.1600-079x.1998.tb00527.x.
9. Bubenik GA, Pang SF, Hacker RR, et al. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res. 1996;21(4):251-256. doi:10.1111/j.1600-079x.1996.tb00294.x.
10. Vician M, Zeman M, Herichová I, et al. Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery. J Pineal Res. 1999;27(3):164-169. doi:10.1111/j.1600-079x.1999.tb00612.x.
11. Raikhlin NT, Kvetnoy IM, Tolkachev VN. Melatonin may be synthesised in enterochromaffin cells. Nature. 1975;255(5506):344-345. doi:10.1038/255344a0.
12. Raikhlin NT, Kvetnoy IM. Melatonin and enterochromaffine cells. Acta Histochem. 1976;55(1):19-24. doi:10.1016/S0065- 1281(76)80092-X.
13. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002;47(10):2336-2348. doi:10.1023/a:1020107915919.
14. Chen CQ, Fichna J, Bashashati M, et al. Distribution, function and physiological role of melatonin in the lower gut.World J Gastroenterol. 2011;17(34):3888-3898. doi:10.3748/wjg.v17.i34.3888.
15. Norman TR, Olver JS. Agomelatine for depression: expanding the horizons?. Expert Opin Pharmacother. 2019;20(6):647-656. doi:10.1080/14656566.2019.1574747.
16. Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5- hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 2003;306(3):954-964. doi:10.1124/jpet.103.051797.
17. Kamal, Maud, et al. "Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers." Journal of Biological Chemistry 290.18 (2015): 11537-11546.
18. Merle A, Delagrange P, Renard P, et al. Effect of melatonin on motility pattern of small intestine in rats and its inhibition by melatonin receptor antagonist S 22153. J Pineal Res. 2000;29(2):116-124. doi:10.1034/j.1600-079x.2000.290208.x.
19. Quastel MR, Rahamımoff R. Effect of melatonin on spontaneous contractions and response to 5-hyroxytryptamine of rat isolated duodenum. Br J Pharmacol Chemother. 1965;24(2):455- 461. doi:10.1111/j.1476-5381.1965.tb01733.x.
20. Harlow HJ, Weekley BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res. 1986;3(3):277-84. doi: 10.1111/j.1600- 079x.1986.tb00750.x. PMID: 3021949.
21. Fioretti MC, Menconi E, Riccardi C. Studio del tipo di antagonismo antiserotoninergico esplicato in citro sullo stomaco di ratto da derivati indolici pinealici [Study on the type of antiserotoninergic antagonism exerted in vitro on rat’s stomach by pineal indole derivatives]. Farmaco Prat. 1974;29(7):401-412.
22. Bubenik GA. The effect of serotonin, N-acetylserotonin, and melatonin on spontaneous contractions of isolated rat intestine. J Pineal Res. 1986;3(1):41-54. doi:10.1111/j.1600- 079x.1986.tb00725.x.
23. Drago F, Macauda S, Salehi S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci. 2002;47(9):1969- 1974. doi:10.1023/a:1019696006677.
24. Kasimay O, Cakir B, Devseren E, et al. Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol. 2005;56(4):543-553.
25. Velarde E, Alonso-Gómez AL, Azpeleta C, et al. Melatonin attenuates the acetylcholine-induced contraction in isolated intestine of a teleost fish. J Comp Physiol B. 2009;179(8):951-959. doi:10.1007/s00360-009-0373-1.
26. Velarde E, Alonso-Gómez AL, Azpeleta C, et al. Melatonin effects on gut motility are independent of the relaxation mediated by the nitrergic system in the goldfish. Comp Biochem Physiol A Mol Integr Physiol. 2011;159(4):367-371. doi:10.1016/j.cbpa.2011.01.024.
27. Barajas-López C, Peres AL, Espinosa-Luna R, et al. Melatonin modulates cholinergic transmission by blocking nicotinic channels in the guinea-pig submucous plexus. Eur J Pharmacol. 1996;312(3):319-325. doi:10.1016/0014-2999(96)00481-5.
28. Reyes-Vázquez C, Naranjo-Rodríguez EB, García-Segoviano JA, et al. Apamin blocks the direct relaxant effect of melatonin on rat ileal smooth muscle. J Pineal Res. 1997;22(1):1-8. doi:10.1111/j.1600-079x.1997.tb00295.x.
29. Fond G, Loundou A, Hamdani N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264(8):651-660. doi:10.1007/s00406-014-0502-z.
30. Song GH, Leng PH, Gwee KA, et al. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut. 2005;54(10):1402-1407. doi:10.1136/gut.2004.062034.
31. Saha L, Malhotra S, Rana S, et al. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol. 2007;41(1):29-32. doi:10.1097/MCG.0b013e31802df84c.
32. Lu WZ, Song GH, Gwee KA, et al. The effects of melatonin on colonic transit time in normal controls and IBS patients. Dig Dis Sci. 2009;54(5):1087-1093. doi:10.1007/s10620-008-0463-z.
33. Chojnacki C, Walecka-Kapica E, Lokieć K, et al. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. Endokrynol Pol. 2013;64(2):114-120.
34. Balakina IV, Mironova TIa, Golovanova EN. Efficacy and safety of valdoxan in patients with irritable bowel syndrome. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(4):90-92.

APA	Kacar E, Sahinturk S, Yardimci A, ULKER ERTUGRUL N, Tan F, Bulmus O, ERCAN Z, serhatlioglu i (2022). Effect of agomelatine on intestinal smooth muscle contractility in rats. , 1258 - 1262. 10.5455/annalsmedres.2022.05.156
Chicago	Kacar Emine,Sahinturk Serdar,Yardimci Ahmet,ULKER ERTUGRUL Nazife,Tan Fatih,Bulmus Ozgur,ERCAN ZUBEYDE,serhatlioglu ihsan Effect of agomelatine on intestinal smooth muscle contractility in rats. (2022): 1258 - 1262. 10.5455/annalsmedres.2022.05.156
MLA	Kacar Emine,Sahinturk Serdar,Yardimci Ahmet,ULKER ERTUGRUL Nazife,Tan Fatih,Bulmus Ozgur,ERCAN ZUBEYDE,serhatlioglu ihsan Effect of agomelatine on intestinal smooth muscle contractility in rats. , 2022, ss.1258 - 1262. 10.5455/annalsmedres.2022.05.156
AMA	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i Effect of agomelatine on intestinal smooth muscle contractility in rats. . 2022; 1258 - 1262. 10.5455/annalsmedres.2022.05.156
Vancouver	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i Effect of agomelatine on intestinal smooth muscle contractility in rats. . 2022; 1258 - 1262. 10.5455/annalsmedres.2022.05.156
IEEE	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i "Effect of agomelatine on intestinal smooth muscle contractility in rats." , ss.1258 - 1262, 2022. 10.5455/annalsmedres.2022.05.156
ISNAD	Kacar, Emine vd. "Effect of agomelatine on intestinal smooth muscle contractility in rats". (2022), 1258-1262. https://doi.org/10.5455/annalsmedres.2022.05.156

APA	Kacar E, Sahinturk S, Yardimci A, ULKER ERTUGRUL N, Tan F, Bulmus O, ERCAN Z, serhatlioglu i (2022). Effect of agomelatine on intestinal smooth muscle contractility in rats. Annals of Medical Research, 29(11), 1258 - 1262. 10.5455/annalsmedres.2022.05.156
Chicago	Kacar Emine,Sahinturk Serdar,Yardimci Ahmet,ULKER ERTUGRUL Nazife,Tan Fatih,Bulmus Ozgur,ERCAN ZUBEYDE,serhatlioglu ihsan Effect of agomelatine on intestinal smooth muscle contractility in rats. Annals of Medical Research 29, no.11 (2022): 1258 - 1262. 10.5455/annalsmedres.2022.05.156
MLA	Kacar Emine,Sahinturk Serdar,Yardimci Ahmet,ULKER ERTUGRUL Nazife,Tan Fatih,Bulmus Ozgur,ERCAN ZUBEYDE,serhatlioglu ihsan Effect of agomelatine on intestinal smooth muscle contractility in rats. Annals of Medical Research, vol.29, no.11, 2022, ss.1258 - 1262. 10.5455/annalsmedres.2022.05.156
AMA	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i Effect of agomelatine on intestinal smooth muscle contractility in rats. Annals of Medical Research. 2022; 29(11): 1258 - 1262. 10.5455/annalsmedres.2022.05.156
Vancouver	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i Effect of agomelatine on intestinal smooth muscle contractility in rats. Annals of Medical Research. 2022; 29(11): 1258 - 1262. 10.5455/annalsmedres.2022.05.156
IEEE	Kacar E,Sahinturk S,Yardimci A,ULKER ERTUGRUL N,Tan F,Bulmus O,ERCAN Z,serhatlioglu i "Effect of agomelatine on intestinal smooth muscle contractility in rats." Annals of Medical Research, 29, ss.1258 - 1262, 2022. 10.5455/annalsmedres.2022.05.156
ISNAD	Kacar, Emine vd. "Effect of agomelatine on intestinal smooth muscle contractility in rats". Annals of Medical Research 29/11 (2022), 1258-1262. https://doi.org/10.5455/annalsmedres.2022.05.156